IDH1 and central nervous system cancer: The IDH inhibitor IDH-C35 significantly enhances CD8 + T cell infiltration and prolongs the survival of glioma-associated antigens vaccinated mice challenged with IDHmt glioma (Kohanbash et al., 2017).